ロード中...
CLINICALLY IMPORTANT CHANGES IN SHORT FORM-36 SCALES FOR USE IN RHEUMATOID ARTHRITIS CLINICAL TRIALS: THE IMPACT OF LOW RESPONSIVENESS
OBJECTIVE: Despite wide use of the Short-Form 36 (SF-36) in clinical trials of rheumatoid arthritis (RA), estimates of minimal clinically important improvement (MCII) for its scales are not well-established. We estimated MCIIs for SF-36 scales in patients with active RA. METHODS: In this prospective...
保存先:
| 出版年: | Arthritis Care Res (Hoboken) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245332/ https://ncbi.nlm.nih.gov/pubmed/24980417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22392 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|